Dominant follicle-targeted nanocarriers for GH delivery to alleviate premature ovarian insufficiency
Materials Today Bio · 2025-08 · 33 · 101930
DOI: 10.1016/j.mtbio.2025.101930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2025-08. Verfasst von Shao Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Medicine, Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical Unive…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Key Technologies Research and Development Program, National Key Research and Development Program of China, Science and Technology Development Plan of Shandong Province.
Abstract (Originalsprache)
Premature ovarian insufficiency (POI) is characterized by ovarian functional damage, leading to infertility and severe complications. Current treatment is merely to relieve the clinical symptoms by hormone supplementation. Growth hormone (GH) shows efficacy in restoring ovarian function. However, GH has poor targeting specificity and stability, which limits its clinical application. Dominant follicles play a vital role in ovarian endocrine and reproductive function. Zona pellucida glycoprotein 3 (ZP3) is a specific component of the zona pellucida around the oocyte and is tightly associated with the dominant follicle. Therefore, we constructed a GH-loaded complex zeolitic imidazolate frameworks-8 (ZIF8)-GH@ZP3Ab, which uses ZIF8 to load GH and ZP3 antibody (ZP3Ab) to specifically bind ZP3. The results showed that ZIF8-GH@ZP3Ab had a good targeting ability to ovaries, especially the dominant follicles. This approach promoted the development of dominant follicles without increasing the depletion of primordial follicles. In vivo experiments demonstrated that ZIF8-GH@ZP3Ab promoted angiogenesis, reduced oxidative stress and apoptosis, and enhanced the secretion of IGF-1 in antral follicles. These effects restored ovarian function and fertility in cisplatin-induced POI in mice. In vitro experiments indicated that both ZIF8 and GH can protect granulosa cells from cisplatin-induced oxidative stress and apoptosis. In conclusion, ZIF8-GH@ZP3Ab is promising as an effective nanomedicine for the treatment of POI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Reproductive Medicine, Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China.
- Shandong Key Laboratory of Reproductive Research and Birth Defect Prevention, Shandong First Medical University, Jinan, Shandong, 250021, China.
- Jinan Engineering Laboratory of Reproductive Diagnosis and Treatment Technology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China.
- Shandong University, Jinan, Shandong, 250000, China.
- Department of Obstetrics and Gynecology, Zibo Municipal Hospital, Zibo, Shandong, 255400, China.
- Shandong Second Medical University, Weifang, Shandong, 252422, China.
Förderung
- Key Technologies Research and Development Program
- National Key Research and Development Program of China
- Science and Technology Development Plan of Shandong Province
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
- Key Technology Research and Development Program of Shandong
Zitieren
APA
Yang, S., Sun, Y., Luo, W., Zhou, X., Gu, X., Zhang, W., Zhu, H., Wu, W., Wu, X., Yu, M., & Wang, S. (2025). Dominant follicle-targeted nanocarriers for GH delivery to alleviate premature ovarian insufficiency. Materials Today Bio, 33, 101930. https://doi.org/10.1016/j.mtbio.2025.101930
Vancouver
Yang S, Sun Y, Luo W, Zhou X, Gu X, Zhang W, et al. Dominant follicle-targeted nanocarriers for GH delivery to alleviate premature ovarian insufficiency. Materials Today Bio. 2025;33:101930. doi:10.1016/j.mtbio.2025.101930
BibTeX
@article{Yang2025,
author = {Yang, Shao and Sun, Yawei and Luo, Wei and Zhou, Xiaofeng and Gu, Xiao and Zhang, Wenzhe and Zhu, Huashan and Wu, Wenjia and Wu, Xueying and Yu, Mengru and Wang, Shan},
title = {Dominant follicle-targeted nanocarriers for GH delivery to alleviate premature ovarian insufficiency},
journal = {Materials Today Bio},
year = {2025},
volume = {33},
pages = {101930},
doi = {10.1016/j.mtbio.2025.101930}
}
EUVIMED